{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:45:20Z","timestamp":1787028320934,"version":"build-2736575974"},"reference-count":143,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute of Biomedicine (iBiMED)","award":["UID\/BIM\/04501\/2020"],"award-info":[{"award-number":["UID\/BIM\/04501\/2020"]}]},{"name":"CCDRC (CENTRO2020)","award":["MEDISIS project"],"award-info":[{"award-number":["MEDISIS project"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Myotonic dystrophy type 1 (DM1) is an autosomal dominant hereditary and multisystemic disease, characterized by progressive distal muscle weakness and myotonia. Despite huge efforts, the pathophysiological mechanisms underlying DM1 remain elusive. In this review, the metabolic alterations observed in patients with DM1 and their connection with lipin proteins are discussed. We start by briefly describing the epidemiology, the physiopathological and systemic features of DM1. The molecular mechanisms proposed for DM1 are explored and summarized. An overview of metabolic syndrome, dyslipidemia, and the summary of metabolic alterations observed in patients with DM1 are presented. Patients with DM1 present clinical evidence of metabolic alterations, namely increased levels of triacylglycerol and low-density lipoprotein, increased insulin and glucose levels, increased abdominal obesity, and low levels of high-density lipoprotein. These metabolic alterations may be associated with lipins, which are phosphatidate phosphatase enzymes that regulates the triacylglycerol levels, phospholipids, lipid signaling pathways, and are transcriptional co-activators. Furthermore, lipins are also important for autophagy, inflammasome activation and lipoproteins synthesis. We demonstrate the association of lipin with the metabolic alterations in patients with DM1, which supports further clinical studies and a proper exploration of lipin proteins as therapeutic targets for metabolic syndrome, which is important for controlling many diseases including DM1.<\/jats:p>","DOI":"10.3390\/ijerph18041794","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:45:00Z","timestamp":1613155500000},"page":"1794","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9513-8197","authenticated-orcid":false,"given":"Tiago","family":"Mateus","sequence":"first","affiliation":[{"name":"Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-1809","authenticated-orcid":false,"given":"Filipa","family":"Martins","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-5821","authenticated-orcid":false,"given":"Alexandra","family":"Nunes","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":false,"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-5797","authenticated-orcid":false,"given":"Sandra","family":"Rebelo","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/CON.0000000000000793","article-title":"Myotonic Muscular Dystrophies","volume":"25","author":"Johnson","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JND-180328","article-title":"Myotonic Dystrophy Type 2\u2013Data from the Serbian Registry","volume":"5","author":"Bozovic","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000444018","article-title":"An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy","volume":"46","author":"Vanacore","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11033-014-3791-4","article-title":"Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts","volume":"42","author":"Cisneros","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic Dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol. Clin."},{"key":"ref_6","unstructured":"Maga\u00f1a, J.J., Surez-Snchez, R., Leyva-Garca, N., Cisneros, B., and Hernndez-Hernndez, O. (2012). Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1. Advances in Protein Kinases, InTech."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","article-title":"Myotonic dystrophy: Emerging mechanisms for DM1 and DM2","volume":"1772","author":"Cho","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis, S., Okkersen, K., Widomska, J., Blom, P., \u2019t Hoen, P.A.C., van Engelen, B., and Glennon, J.C. (2019). Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.01229"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Takada, H. (2018). Lipid Metabolism in Myotonic Dystrophy. Myotonic Dystrophy, Springer.","DOI":"10.1007\/978-981-13-0508-5_10"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbrc.2019.01.031","article-title":"Lipin-1 is a novel substrate of protein phosphatase PGAM5","volume":"509","author":"Okuno","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molmet.2013.11.008","article-title":"Lipin-1 and lipin-3 together determine adiposity in vivo","volume":"3","author":"Csaki","year":"2014","journal-title":"Mol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000368661","article-title":"Lipin Family Proteins\u2014Key Regulators in Lipid Metabolism","volume":"66","author":"Chen","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32883","DOI":"10.1074\/jbc.M503885200","article-title":"Alternatively Spliced Lipin Isoforms Exhibit Distinct Expression Pattern, Subcellular Localization, and Role in Adipogenesis","volume":"280","author":"Phan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1\u03b1\/PPAR\u03b1 regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ncl.2016.06.017","article-title":"The Epidemiology of Neuromuscular Diseases","volume":"34","author":"Bhatt","year":"2016","journal-title":"Neurol. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000369343","article-title":"Prevalence of Muscular Dystrophies: A Systematic Literature Review","volume":"43","author":"Theadom","year":"2014","journal-title":"Neuroepidemiology"},{"key":"ref_17","unstructured":"LaPelusa, A., and Kentris, M. (2020). Muscular Dystrophy. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00421-017-3558-4","article-title":"Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1","volume":"117","author":"Esposito","year":"2017","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1128\/MCB.23.16.5489-5501.2003","article-title":"Alternative Splicing Controls Myotonic Dystrophy Protein Kinase Structure, Enzymatic Activity, and Subcellular Localization","volume":"23","author":"Wansink","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1042\/BST0371281","article-title":"Pathogenic mechanisms of myotonic dystrophy","volume":"37","author":"Lee","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1021\/bi992142f","article-title":"Myotonic Dystrophy Protein Kinase Domains Mediate Localization, Oligomerization, Novel Catalytic Activity, and Autoinhibition \u2020","volume":"39","author":"Bush","year":"2000","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification","volume":"172","author":"Dogan","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/CON.0000000000000414","article-title":"The Dystrophic and Nondystrophic Myotonias","volume":"22","author":"Sansone","year":"2016","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","article-title":"Myotonic dystrophy","volume":"27","author":"Turner","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","article-title":"Myotonic dystrophy: Disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes","volume":"44","author":"Yum","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/eci.12459","article-title":"Gonadal failure is associated with visceral adiposity in myotonic dystrophies","volume":"45","author":"Passeri","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-019-1019-3","article-title":"Systematic thyroid screening in myotonic dystrophy: Link between thyroid volume and insulin resistance","volume":"14","author":"Espiard","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2019.02.012","article-title":"Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study","volume":"399","author":"Rossi","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nmd.2018.12.002","article-title":"Respiratory dysfunction in myotonic dystrophy type 1: A systematic review","volume":"29","author":"Hawkins","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-14-48","article-title":"Structural and functional cardiac changes in myotonic dystrophy type 1: A cardiovascular magnetic resonance study","volume":"14","author":"Hermans","year":"2012","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.repc.2017.10.011","article-title":"Importance of three-dimensional speckle tracking in the assessment of left atrial and ventricular dysfunction in patients with myotonic dystrophy type 1","volume":"37","author":"Guedes","year":"2018","journal-title":"Rev. Port. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00392-019-01414-0","article-title":"Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1","volume":"108","author":"Chmielewski","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/hmg\/ddh266","article-title":"Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy","volume":"13","author":"Reyes","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nmd.2004.03.012","article-title":"In situ hybridization analysis of Dmpk mRNA in adult mouse tissues","volume":"14","author":"Sarkar","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/hmg\/9.4.605","article-title":"Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties","volume":"9","author":"Groenen","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"40296","DOI":"10.1074\/jbc.M111.241455","article-title":"Myotonic Dystrophy Protein Kinase Is Critical for Nuclear Envelope Integrity","volume":"286","author":"Harmon","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1021\/bi030045n","article-title":"Novel Phosphorylation Target in the Serum Response Factor MADS Box Regulates \u03b1-Actin Transcription \u2020","volume":"42","author":"Iyer","year":"2003","journal-title":"Biochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0014-5793(01)02283-9","article-title":"Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity","volume":"493","author":"Zhang","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddr343","article-title":"Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: New findings and future challenges","volume":"20","author":"Sicot","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nmd.2010.11.012","article-title":"Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1","volume":"21","author":"Perbellini","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nsmb.2067","article-title":"Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy","volume":"18","author":"Rau","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nmd.2006.12.015","article-title":"Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1","volume":"17","author":"Wheeler","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1083\/jcb.201108113","article-title":"The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing","volume":"196","author":"Yadava","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nsmb.1720","article-title":"Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy","volume":"17","author":"Du","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1086\/383590","article-title":"Myotonic Dystrophy: RNA Pathogenesis Comes into Focus","volume":"74","author":"Ranum","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1172\/JCI129769","article-title":"Nuclear envelope\u2013localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis","volume":"129","author":"Shin","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/hmg\/ddm239","article-title":"Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1","volume":"16","author":"Hino","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-007-0001-z","article-title":"Tyr687 dependent APP endocytosis and abeta production","volume":"32","author":"Rebelo","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1326-5-40","article-title":"Retrieval of the Alzheimer\u2019s amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated","volume":"5","author":"Vieira","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JAD-130095","article-title":"Identification of a Novel Complex A\u03b2PP:Fe65:PP1 that Regulates A\u03b2PP Thr668 Phosphorylation Levels","volume":"35","author":"Rebelo","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"Lo The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic syndrome update","volume":"26","author":"Grundy","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Renna, L.V., Bos\u00e8, F., Iachettini, S., Fossati, B., Saraceno, L., Milani, V., Colombo, R., Meola, G., and Cardani, R. (2017). Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184987"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0404.2009.01237.x","article-title":"Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1","volume":"121","author":"Peric","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1530\/EJE-11-0537","article-title":"Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1","volume":"165","author":"Daniele","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mus.21484","article-title":"Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy","volume":"41","author":"Shieh","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2796.2001.00832.x","article-title":"Increased levels of tPA antigen and tPA\/PAI-1 complex in myotonic dystrophy","volume":"249","author":"Johansson","year":"2001","journal-title":"J. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40618-019-01156-w","article-title":"Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: A retrospective, case\u2013control study","volume":"43","author":"Spaziani","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Johansson, A., Olsson, T., Cederquist, K., Forsberg, H., Holst, J., and Ahren, B. (2002). Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. Eur. J. Endocrinol., 397\u2013405.","DOI":"10.1530\/eje.0.1460397"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/brain\/110.2.469","article-title":"The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy","volume":"110","author":"Hudson","year":"1987","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.24540","article-title":"Metabolic syndrome in patients with myotonic dystrophy type 1","volume":"52","author":"Vujnic","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcn\/80.2.357","article-title":"Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1","volume":"80","author":"Perseghin","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2008.08.037","article-title":"A cross-sectional study for glucose intolerance of myotonic dystrophy","volume":"276","author":"Matsumura","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Heatwole, C.R., Eichinger, K.J., Friedman, D.I., Hilbert, J.E., Jackson, C.E., Logigian, E.L., Martens, W.B., McDermott, M.P., Pandya, S.K., and Quinn, C. (2011). Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1\/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1. Arch. Neurol., 68.","DOI":"10.1001\/archneurol.2010.227"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Perna, A., Maccora, D., Rossi, S., Nicoletti, T.F., Zocco, M.A., Riso, V., Modoni, A., Petrucci, A., Valenza, V., and Grieco, A. (2020). High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00394"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0317167100028675","article-title":"Hypertriglyceridemia and Lower LDL Cholesterol Concentration in Relation to Apolipoprotein E Phenotypes in Myotonic Dystrophy","volume":"16","author":"Moorjani","year":"1989","journal-title":"Can. J. Neurol. Sci. J. Can. Sci. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.nmd.2016.06.394","article-title":"Liver functional impairment in myotonic dystrophy type 1","volume":"26","author":"Takada","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Renna, L.V., Bos\u00e8, F., Brigonzi, E., Fossati, B., Meola, G., and Cardani, R. (2019). Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214254"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddy432","article-title":"Transcriptome alterations in myotonic dystrophy skeletal muscle and heart","volume":"28","author":"Wang","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1074\/jbc.M110.117747","article-title":"Characterization of the Human LPIN1 -encoded Phosphatidate Phosphatase Isoforms","volume":"285","author":"Han","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lutkewitte, A.J., and Finck, B.N. (2020). Regulation of Signaling and Metabolism by Lipin-mediated Phosphatidic Acid Phosphohydrolase Activity. Biomolecules, 10.","DOI":"10.3390\/biom10101386"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/1873-3468.13563","article-title":"Phosphatidic acid in membrane rearrangements","volume":"593","author":"Zhukovsky","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/83685","article-title":"Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin","volume":"27","author":"Phan","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1194\/jlr.R800019-JLR200","article-title":"Thematic Review Series: Glycerolipids. Multiple roles for lipins\/phosphatidate phosphatase enzymes in lipid metabolism","volume":"49","author":"Reue","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1101\/gad.1638008","article-title":"Phosphatidic acid mediates demyelination in Lpin1 mutant mice","volume":"22","author":"Nadra","year":"2008","journal-title":"Genes Dev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1073\/pnas.1213493110","article-title":"Mice with an adipocyte-specific lipin 1 separation-of-function allele reveal unexpected roles for phosphatidic acid in metabolic regulation","volume":"110","author":"Mitra","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.febslet.2011.05.035","article-title":"Lipin-1\u03b3 isoform is a novel lipid droplet-associated protein highly expressed in the brain","volume":"585","author":"Wang","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1194\/jlr.R800052-JLR200","article-title":"Lipin proteins and metabolic homeostasis","volume":"50","author":"Reue","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1194\/jlr.S091769","article-title":"Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: Metabolic and inflammatory disorders","volume":"60","author":"Reue","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2017.05.035","article-title":"Hepatic Diacylglycerol-Associated Protein Kinase C\u03b5 Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans","volume":"19","author":"Gilijamse","year":"2017","journal-title":"Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2009.01.007","article-title":"TORC2 Regulates Hepatic Insulin Signaling via a Mammalian Phosphatidic Acid Phosphatase, LIPIN1","volume":"9","author":"Ryu","year":"2009","journal-title":"Cell Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1194\/jlr.M062588","article-title":"Lipin-1 expression is critical for keratinocyte differentiation","volume":"57","author":"Chae","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.4049\/jimmunol.1400238","article-title":"Lipin-1 Integrates Lipid Synthesis with Proinflammatory Responses during TLR Activation in Macrophages","volume":"193","author":"Meana","year":"2014","journal-title":"J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbalip.2009.02.002","article-title":"TLR-4 mediated group IVA phospholipase A2 activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent","volume":"1791","author":"Grkovich","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"32978","DOI":"10.1074\/jbc.M605935200","article-title":"Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Human U937 Macrophages Is Phosphatidic Acid Phosphohydrolase-1-dependent","volume":"281","author":"Grkovich","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.4049\/jimmunol.1003279","article-title":"Subcellular Localization and Role of Lipin-1 in Human Macrophages","volume":"186","author":"Valdearcos","year":"2011","journal-title":"J. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"34896","DOI":"10.1074\/jbc.M804007200","article-title":"Lipin1 Is a Key Factor for the Maturation and Maintenance of Adipocytes in the Regulatory Network with CCAAT\/Enhancer-binding Protein \u03b1 and Peroxisome Proliferator-activated Receptor \u03b3 2","volume":"283","author":"Koh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Chen, Z., Gropler, M.C., Mitra, M.S., and Finck, B.N. (2012). Complex Interplay between the Lipin 1 and the Hepatocyte Nuclear Factor 4 \u03b1 (HNF4\u03b1) Pathways to Regulate Liver Lipid Metabolism. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051320"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1194\/jlr.M800013-JLR200","article-title":"Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically","volume":"49","author":"Manmontri","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1128\/MCB.01671-09","article-title":"Lipin 1 Represses NFATc4 Transcriptional Activity in Adipocytes To Inhibit Secretion of Inflammatory Factors","volume":"30","author":"Kim","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Chandran, S., Schilke, R.M., Blackburn, C.M.R., Yurochko, A., Mirza, R., Scott, R.S., Finck, B.N., and Woolard, M.D. (2020). Lipin-1 Contributes to IL-4 Mediated Macrophage Polarization. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00787"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Liu, G.-H., and Gerace, L. (2009). Sumoylation Regulates Nuclear Localization of Lipin-1\u03b1 in Neuronal Cells. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007031"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00415-013-6984-1","article-title":"Vitamin D deficiency in myotonic dystrophy type 1","volume":"260","author":"Terracciano","year":"2013","journal-title":"J. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.2337\/db05-1688","article-title":"Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor Activation","volume":"55","author":"Rasouli","year":"2006","journal-title":"Diabetes"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bbalip.2015.09.001","article-title":"Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy","volume":"1851","author":"Paran","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"158438","DOI":"10.1016\/j.bbalip.2019.03.010","article-title":"Substrate channeling in the glycerol-3-phosphate pathway regulates the synthesis, storage and secretion of glycerolipids","volume":"1865","author":"Lee","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"ref_100","first-page":"102","article-title":"Adipocytes spectrum\u2014From homeostasia to obesity and its associated pathology","volume":"219","author":"Amalinei","year":"2018","journal-title":"Ann. Anat. Anat. Anzeiger"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Foufelle","year":"2010","journal-title":"Diabetes, Obes. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2006.09.007","article-title":"Pathophysiology of insulin resistance","volume":"20","author":"Sesti","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic Syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biochi.2019.07.014","article-title":"Skeletal muscle atrogenes: From rodent models to human pathologies","volume":"166","author":"Taillandier","year":"2019","journal-title":"Biochimie"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1073\/pnas.022634399","article-title":"Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin","volume":"99","author":"Huffman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1194\/jlr.R012120","article-title":"Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders","volume":"53","author":"Mitchell","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1074\/jbc.M109.072488","article-title":"Insulin-stimulated Interaction with 14-3-3 Promotes Cytoplasmic Localization of Lipin-1 in Adipocytes","volume":"285","author":"Harris","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-020-02756-8","article-title":"MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway","volume":"11","author":"Song","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wang, M., Weng, W.-C., Stock, L., Lindquist, D., Martinez, A., Gourdon, G., Timchenko, N., Snape, M., and Timchenko, L. (2019). Correction of Glycogen Synthase Kinase 3\u03b2 in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice. Mol. Cell. Biol., 39.","DOI":"10.1128\/MCB.00155-19"},{"key":"ref_111","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M600272-JLR200","article-title":"A role of lipin in human obesity and insulin resistance: Relation to adipocyte glucose transport and GLUT4 expression","volume":"48","author":"Hoffstedt","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/17460875.1.1.91","article-title":"Lipin: A determinant of adiposity, insulin sensitivity and energy balance","volume":"1","author":"Reue","year":"2006","journal-title":"Future Lipidol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Rashid, T., Nemazanyy, I., Paolini, C., Tatsuta, T., Crespin, P., Villeneuve, D., Brodesser, S., Benit, P., Rustin, P., and Baraibar, M.A. (2019). Lipin1 deficiency causes sarcoplasmic reticulum stress and chaperone-responsive myopathy. EMBO J., 38.","DOI":"10.15252\/embj.201899576"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/archdischild-2014-307663","article-title":"A diagnostic approach to recurrent myalgia and rhabdomyolysis in children","volume":"100","author":"Chan","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1568026618666180523104541","article-title":"SCAP\/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy","volume":"18","author":"Cheng","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/13816128113199990486","article-title":"Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer","volume":"20","author":"Guo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2005.01.012","article-title":"SREBP Pathway Responds to Sterols and Functions as an Oxygen Sensor in Fission Yeast","volume":"120","author":"Hughes","year":"2005","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cmet.2011.04.001","article-title":"Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1a","volume":"13","author":"Im","year":"2011","journal-title":"Cell Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI119746","article-title":"Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene","volume":"100","author":"Shimano","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_121","first-page":"6260","article-title":"Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin","volume":"12","author":"Matheu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nmd.2017.10.007","article-title":"Mitochondrial dysfunction in myotonic dystrophy type 1","volume":"28","author":"Gramegna","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/brain\/120.10.1699","article-title":"Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study","volume":"120","author":"Barnes","year":"1997","journal-title":"Brain"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00936882","article-title":"Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy","volume":"242","author":"Ihara","year":"1995","journal-title":"J. Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bbamem.2017.04.007","article-title":"Lipin proteins and glycerolipid metabolism: Roles at the ER membrane and beyond","volume":"1859","author":"Zhang","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2008.07.079","article-title":"Potential role of lipin-1 in exercise-induced mitochondrial biogenesis","volume":"374","author":"Higashida","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2004.12.002","article-title":"Lipin, a lipodystrophy and obesity gene","volume":"1","author":"Phan","year":"2005","journal-title":"Cell Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"29558","DOI":"10.1074\/jbc.M403506200","article-title":"Lipin Expression Preceding Peroxisome Proliferator-activated Receptor-\u03b3 Is Critical for Adipogenesis in Vivo and in Vitro","volume":"279","author":"Phan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/en.2003-0580","article-title":"Minireview: The Adipocyte\u2014At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis","volume":"144","author":"Rajala","year":"2003","journal-title":"Endocrinology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mce.2016.10.011","article-title":"The expanding problem of adipose depot remodeling and postnatal adipocyte progenitor recruitment","volume":"445","author":"Hepler","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tem.2015.01.006","article-title":"Insulin resistance and impaired adipogenesis","volume":"26","author":"Gustafson","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1074\/jbc.M112.342915","article-title":"Lipin-2 Reduces Proinflammatory Signaling Induced by Saturated Fatty Acids in Macrophages","volume":"287","author":"Valdearcos","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.bbalip.2019.06.003","article-title":"The role of lipins in innate immunity and inflammation","volume":"1864","author":"Balboa","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12775","article-title":"Innovation in metabolomics to improve personalized healthcare","volume":"1346","author":"Cacciatore","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2217\/14622416.8.9.1243","article-title":"Metabolic fingerprinting as a diagnostic tool","volume":"8","author":"Ellis","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"103888","DOI":"10.1016\/j.jprot.2020.103888","article-title":"Investigation of spectroscopic and proteomic alterations underlying prostate carcinogenesis","volume":"226","author":"Felgueiras","year":"2020","journal-title":"J. Proteom."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/2213235X06666180521084551","article-title":"Spectroscopic Features of Cancer Cells: FTIR Spectroscopy as a Tool for Early Diagnosis","volume":"6","author":"Santos","year":"2018","journal-title":"Curr. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/2213235X07666181122124106","article-title":"Understanding Prostate Cancer Cells Metabolome: A Spectroscopic Approach","volume":"6","author":"Santos","year":"2019","journal-title":"Curr. Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1096\/fj.201800361R","article-title":"Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice","volume":"33","author":"Schweitzer","year":"2019","journal-title":"FASEB J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/1743132812Y.0000000144","article-title":"Peripheral neuropathy in patients with myotonic dystrophy type 1","volume":"35","author":"Peric","year":"2013","journal-title":"Neurol. Res."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/4\/1794\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:23:23Z","timestamp":1760160203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/4\/1794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":143,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijerph18041794"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18041794","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}